Summary of CVOT With DPP-4 Inhibitors These studies therefore show that DPP-4 inhibitors are safe from a cardiovascular point of view in subjects at risk for cardiovascular diseases and type 2 diabetes and, also, that risk for other adverse events, such as hypoglycemia or pancreatitis, is low
With more choices, HCPs are better equipped to tailor treatment approaches and support patients who want to gain control of their weight, and this milestone approval underscores exactly that kind of choice, said Timothy Garvey, MD, professor of medicine and director of the Diabetes Research Center at the University of Alabama at Birmingham
[11C]-Labeled metformin distribution in the liver and small intestine using dynamic positron emission tomography in mice demonstrates tissue-specific transporter dependency
The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events (MACE) with semaglutide in non-diabetic patients with obesity and prior cardiovascular events [4,5]
Many people use glutathione for skin lightening, anti-ageing, detoxification, and pigmentation reduction